XRP is back in the spotlight. This time, not because of a courtroom drama or a celebrity endorsement—but thanks to a healthcare company betting big on its future. Wellgistics Health, a publicly traded U.S. firm, has filed with the SEC to use XRP as part of its corporate treasury. They’re not dabbling either. They’ve secured a $50 million credit line to build out their XRP reserves.
And investors? They’re paying attention. XRP’s price is ticking upward, and the market is buzzing with fresh energy.
A First for U.S. Healthcare—and for XRP
Wellgistics (NASDAQ: WGRX), based in Florida, is not your typical crypto adopter. They’re not a fintech startup or a blockchain venture. They distribute healthcare products.
But now, they’ve decided to carve out space for XRP in their books.
The company quietly filed with the U.S. Securities and Exchange Commission, declaring its intent to hold XRP as a treasury asset. That puts them ahead of any other U.S.-listed healthcare company in terms of crypto adoption. And the dollar amount? Up to $50 million. Not loose change.
In simple terms: they’re treating XRP like digital cash—something you’d keep in reserve, like you would with U.S. dollars or short-term bonds.
The XRP Price Spike: Coincidence or Confidence?
Just days after the Wellgistics news hit wires, XRP’s price showed movement. Not a skyrocket, but enough to catch the eye of traders.
One sentence: XRP was trading up roughly 4.3% in 24 hours as of Friday morning.
That bump may look small in isolation, but paired with broader investor sentiment and recent whale activity, it paints a bullish picture.
The timing of the announcement couldn’t have been better. Ripple’s legal issues with the SEC are slowly unwinding. Regulatory uncertainty, though far from over, feels less intimidating now than it did a year ago.
And this Wellgistics move? It’s a confidence vote. Maybe even a domino.
Healthcare Meets Crypto: What Could Go Wrong—or Right?
Using XRP in healthcare isn’t just quirky. It’s potentially game-changing—for logistics, payment speed, and cross-border transactions.
Wellgistics is leaning into XRP not just as an asset, but as a possible operational tool down the line. Treasury now, transactions later.
There are a few reasons a healthcare distributor might want this:
-
Fast settlements for overseas suppliers
-
Lower costs on international purchases
-
Hedge against fiat currency risk
They’re not alone in the thought process either. Companies like MicroStrategy have long used Bitcoin in their balance sheets. But this is different—XRP is built for payments, not just storage of value.
And let’s not forget: the healthcare supply chain is global, fragmented, and expensive. Even small efficiency wins could be worth millions.
The XRP Effect: Investors Get Interested
Market watchers are already linking Wellgistics’ announcement to a wave of new retail interest in XRP.
CryptoQuant reports increased on-chain activity for XRP wallets holding between $10,000 and $1 million. That’s the mid-tier investor band—sometimes called “sharks” in crypto-speak.
Here’s how XRP has been trading over the past week:
| Date | Price (USD) | 24h Volume | Market Cap Rank |
|---|---|---|---|
| July 21 | $0.62 | $1.6B | #7 |
| July 22 | $0.63 | $1.9B | #7 |
| July 23 | $0.64 | $2.1B | #6 |
| July 24 | $0.65 | $2.4B | #6 |
| July 25 | $0.67 | $2.7B | #6 |
Some of the growth is speculative. But some of it? It’s tied to the belief that if more listed companies start holding XRP, demand could rise—and so could price.
SEC Filing Sparks Talk, Not Just Headlines
Wellgistics isn’t just making a PR move. The SEC filing suggests this is a serious, compliance-checked financial decision.
They’re not simply buying XRP off a crypto exchange and calling it a day. They’ve structured it around a credit facility, meaning:
-
The $50 million isn’t just from reserves—they’re leveraging external financing
-
This opens a new frontier for structured crypto financing in the corporate world
And that matters because it sets precedent. Other firms looking to experiment with blockchain assets might now point to this as a proof-of-concept.
One sentence: it’s not wild speculation if it’s backed by paperwork.
What’s Next? Watch the Dominos
If XRP continues to gain corporate allies, its use case strengthens.
For now, Wellgistics is just one name. But all it takes is a few more before this goes from niche to trend. The market’s watching.

